Centene Corporation has initiated legal action against the Centers for Medicare & Medicaid Services (CMS) following a downgrade in its Medicare Advantage ratings. Concurrently, UnitedHealthcare has filed a lawsuit against CMS, claiming that a phone call negatively impacted its Star ratings. These developments come amid scrutiny of private Medicare Advantage plans, as a government watchdog has called for increased oversight of these plans, which collectively received $7.5 billion in enhanced payments in 2023, potentially based on questionable patient diagnoses. In another significant move, UnitedHealth Group and Amedisys are reportedly in final negotiations with the Department of Justice (DOJ) to secure their $3.3 billion merger deal, with meetings scheduled for next week to address antitrust concerns regarding their proposed tie-up.
[ABA Antitrust Daily Digest] UnitedHealth and Amedisys reps will meet with DOJ antitrust officials next week in a final attempt to avoid a challenge to their proposed merger. https://t.co/OaZ9Xx3Xxt @BLaw
[ABA Antitrust Daily Digest] UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to challenge their proposed tie-up, according to people familiar…
UnitedHealth Group and Amedisys leaders are reportedly expected to meet with officials from the Department of Justice to discuss their pending deal. https://t.co/O7cVxNU806